Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086161839> ?p ?o ?g. }
- W2086161839 endingPage "919" @default.
- W2086161839 startingPage "904" @default.
- W2086161839 abstract "Oxcarbazepine is a new antiepileptic drug (AED) that has been registered in more than 50 countries worldwide since 1990 and recently received approval in the United States and the European Union. Oxcarbazepine is a keto analog of carbamazepine and has a more favorable pharmacokinetic profile. It is rapidly absorbed after oral administration and undergoes rapid and almost complete reductive metabolism to form the pharmacologically active 10-monohydroxy derivative. Oxcarbazepine exhibits linear pharmacokinetics, no autoinduction, and minimal interaction with other AEDs. Ten controlled trials demonstrated that oxcarbazepine is safe and efficacious in the treatment of partial seizures across a wide range of ages (children to adults), situations (recent onset to treatment-resistant epilepsy), and uses (monotherapy and adjunctive therapy). The most common treatment-emergent adverse events are related to the central nervous system. Treatment-emergent hyponatremia (defined as serum sodium level < 125 mEq/L) occurred in 3% of patients treated with oxcarbazepine in clinical trials. According to the efficacy and safety profile established in the controlled trials, oxcarbazepine represents an important new treatment option indicated for monotherapy and adjunctive therapy in adults with partial seizures and as adjunctive therapy in children aged 4 years or older with partial seizures. Although structurally similar to carbamazepine, significant differences exist in the pharmacokinetics, drug interaction potential, adverse-effect profile, and dosage and titration between these two agents, and they should be considered distinct therapeutic agents." @default.
- W2086161839 created "2016-06-24" @default.
- W2086161839 creator A5002880520 @default.
- W2086161839 date "2001-08-01" @default.
- W2086161839 modified "2023-10-18" @default.
- W2086161839 title "Oxcarbazepine in the Treatment of Epilepsy" @default.
- W2086161839 cites W1732466172 @default.
- W2086161839 cites W1774580137 @default.
- W2086161839 cites W1963839145 @default.
- W2086161839 cites W1967322264 @default.
- W2086161839 cites W1967715258 @default.
- W2086161839 cites W1967876125 @default.
- W2086161839 cites W1968368426 @default.
- W2086161839 cites W1968465698 @default.
- W2086161839 cites W1969946030 @default.
- W2086161839 cites W1976354860 @default.
- W2086161839 cites W1976810263 @default.
- W2086161839 cites W1979819746 @default.
- W2086161839 cites W1983021024 @default.
- W2086161839 cites W1983524837 @default.
- W2086161839 cites W1986901191 @default.
- W2086161839 cites W1990954966 @default.
- W2086161839 cites W1991459693 @default.
- W2086161839 cites W1992206505 @default.
- W2086161839 cites W1992469827 @default.
- W2086161839 cites W1992701784 @default.
- W2086161839 cites W1995716893 @default.
- W2086161839 cites W1998657015 @default.
- W2086161839 cites W1999374340 @default.
- W2086161839 cites W1999919778 @default.
- W2086161839 cites W2000140543 @default.
- W2086161839 cites W2000174965 @default.
- W2086161839 cites W2003163303 @default.
- W2086161839 cites W2005190232 @default.
- W2086161839 cites W2005790595 @default.
- W2086161839 cites W2006064798 @default.
- W2086161839 cites W2010723732 @default.
- W2086161839 cites W2011738314 @default.
- W2086161839 cites W2014872544 @default.
- W2086161839 cites W2022517823 @default.
- W2086161839 cites W2032109763 @default.
- W2086161839 cites W2033405300 @default.
- W2086161839 cites W2033585926 @default.
- W2086161839 cites W2037514286 @default.
- W2086161839 cites W2038031767 @default.
- W2086161839 cites W2039687483 @default.
- W2086161839 cites W2040597207 @default.
- W2086161839 cites W2044166538 @default.
- W2086161839 cites W2059036925 @default.
- W2086161839 cites W2065847144 @default.
- W2086161839 cites W2069283215 @default.
- W2086161839 cites W2072923583 @default.
- W2086161839 cites W2074838078 @default.
- W2086161839 cites W2075252466 @default.
- W2086161839 cites W2076162205 @default.
- W2086161839 cites W2078546486 @default.
- W2086161839 cites W2078784493 @default.
- W2086161839 cites W2080109885 @default.
- W2086161839 cites W2082738860 @default.
- W2086161839 cites W2087388267 @default.
- W2086161839 cites W2087398915 @default.
- W2086161839 cites W2089130274 @default.
- W2086161839 cites W2090336174 @default.
- W2086161839 cites W2093392404 @default.
- W2086161839 cites W2095558066 @default.
- W2086161839 cites W2098517987 @default.
- W2086161839 cites W2104489235 @default.
- W2086161839 cites W2108083324 @default.
- W2086161839 cites W2108104758 @default.
- W2086161839 cites W2115074429 @default.
- W2086161839 cites W2118506040 @default.
- W2086161839 cites W2135236787 @default.
- W2086161839 cites W2140419215 @default.
- W2086161839 cites W2147863158 @default.
- W2086161839 cites W2157944766 @default.
- W2086161839 cites W2320058521 @default.
- W2086161839 cites W2322086287 @default.
- W2086161839 cites W2325560622 @default.
- W2086161839 cites W3190290111 @default.
- W2086161839 cites W4234221140 @default.
- W2086161839 cites W4238690145 @default.
- W2086161839 cites W4239833577 @default.
- W2086161839 cites W4242391106 @default.
- W2086161839 cites W4246335939 @default.
- W2086161839 cites W6801438 @default.
- W2086161839 doi "https://doi.org/10.1592/phco.21.11.904.34513" @default.
- W2086161839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11718497" @default.
- W2086161839 hasPublicationYear "2001" @default.
- W2086161839 type Work @default.
- W2086161839 sameAs 2086161839 @default.
- W2086161839 citedByCount "243" @default.
- W2086161839 countsByYear W20861618392012 @default.
- W2086161839 countsByYear W20861618392013 @default.
- W2086161839 countsByYear W20861618392014 @default.
- W2086161839 countsByYear W20861618392016 @default.
- W2086161839 countsByYear W20861618392017 @default.
- W2086161839 countsByYear W20861618392018 @default.
- W2086161839 countsByYear W20861618392019 @default.